As the Head of Health Products & Regulatory Science at the Centre of Regulatory Excellence, Dr James Leong is in charge of identifying the educational needs for the various stakeholders involved in regulatory affairs in the Asia Pacific region, and establishing education roadmaps, priorities and deliverables. In this role, he actively onducts roundtable discussions on policy with regulatory affairs professionals across Asia Pacific, as well as research on advancing regulatory sciences. He draws his regulatory experience from his years as a senior regulatory specialist with the Health Sciences Authority of Singapore, where he is a clinical reviewer in addition to managing the post-market benefit-risk assessments and regulatory actions, as well as oversees the training of clinical assessors. In addition to his Masters in clinical pharmacy, he is also Board-certified in pharmacotherapy. His previous clinical experiences include leading the hospital drug information services and heart failure clinic. He obtained his PhD from Cardiff University, focusing on benefit-risk assessment frameworks, communication of regulatory decisions and innovation of regulatory approaches.